Complications After Systematic, Random, and Image-guided Prostate Biopsy

被引:387
作者
Borghesi, Marco [1 ,2 ]
Ahmed, Hashim [3 ]
Nam, Robert [4 ]
Schaeffer, Edward [5 ]
Schiavina, Riccardo [1 ,2 ]
Taneja, Samir [6 ]
Weidner, Wolfgang [7 ]
Loeb, Stacy [8 ]
机构
[1] Univ Bologna, Dept Urol, Bologna, Italy
[2] Univ Bologna, Cardionephrothorac Sci Doctorate, Dept Expt Diagnost & Specialty Med DIMES, Bologna, Italy
[3] UCL, Div Surg & Intervent Sci, London, England
[4] Univ Toronto, Sunnybrook Res Inst, Div Urol, Toronto, ON, Canada
[5] Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA
[6] New York Univ, Langone Med Ctr, Dept Urol, Div Urol Oncol, New York, NY USA
[7] Univ Clin Giessen, Dept Urol Pediat Urol & Androl, Giessen, Germany
[8] NYU, Dept Urol, New York, NY USA
关键词
Prostate biopsy; Complications; MRI-guided biopsy; Infection; Hospitalization; Mortality; PERIPROSTATIC NERVE BLOCK; IMPROVES PAIN-CONTROL; LOW-DOSE ASPIRIN; QUALITY-OF-LIFE; INFECTIOUS COMPLICATIONS; ANTIMICROBIAL PROPHYLAXIS; ERECTILE FUNCTION; ANTIBIOTIC-PROPHYLAXIS; HOSPITAL ADMISSIONS; ACTIVE SURVEILLANCE;
D O I
10.1016/j.eururo.2016.08.004
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Context: Prostate biopsy (PB) represents the gold standard method to confirm the presence of cancer. In addition to traditional random or systematic approaches, a magnetic resonance imaging (MRI)-guided technique has been introduced recently. Objective: To perform a systematic review of complications after transrectal ultrasound (TRUS)-guided, transperineal, and MRI-guided PB. Evidence acquisition: We performed a systematic literature search of Web of Science, Embase, and Scopus databases up to October 2015, according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. Complications and mortality following random, systematic, and image-guided PBs were reviewed. Eighty-five references were included. Evidence synthesis: The most frequent complication after PB was minor and self-limiting bleeding (hematuria and hematospermia), regardless of the biopsy approach. Occurrence of rectal bleeding was comparable for traditional TRUS-guided and image-guided PBs. Almost 25% of patients experienced lower urinary tract symptoms, but only a few had urinary retention, with higher rates after a transperineal approach. Temporary erectile dysfunction was not negligible, with a return to baseline after 1-6 mo. The incidence of infective complications is increasing, with higher rates among men with medical comorbidities and older age. Transperineal and in-bore MRI-targeted biopsy may reduce the risk of severe infectious complications. Mortality after PB is uncommon, regardless of biopsy technique. Conclusions: Complications after PB are frequent but often self-limiting. The incidence of hospitalization due to severe infections is continuously increasing. The patient's general health status, risk factors, and likelihood of antimicrobial resistance should be carefully appraised before scheduling a PB. Patient summary: We reviewed the variety and incidence of complications after prostate biopsy. Even if frequent, complications seldom represent a problem for the patient. The most troublesome complications are infections. To minimize this risk, the patient's medical condition should be carefully evaluated before biopsy. (C) 2016 European Association of Urology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:353 / 365
页数:13
相关论文
共 84 条
[61]   The role of a standardized 36 core template-assisted transperineal prostate biopsy technique in patients with previously negative transrectal ultrasonography-guided prostate biopsies [J].
Pal, Raj P. ;
Elmussareh, Muhammad ;
Chanawani, Malek ;
Khan, Masood A. .
BJU INTERNATIONAL, 2012, 109 (03) :367-371
[62]   MR imaging-guided prostate biopsy: technical features and preliminary results [J].
Panebianco, Valeria ;
Barchetti, Flavio ;
Manenti, Guglielmo ;
Aversa, Tommaso ;
Catalano, Carlo ;
Simonetti, Giovanni .
RADIOLOGIA MEDICA, 2015, 120 (06) :571-578
[63]   Control of Infective Complications of Transrectal Prostate Biopsy [J].
Park, Dong Soo ;
Hwang, Jin Ho ;
Choi, Don Kyung ;
Gong, In Hyuck ;
Hong, Young Kwon ;
Park, Sujin ;
Oh, Jong Jin .
SURGICAL INFECTIONS, 2014, 15 (04) :431-436
[64]   Transperineal In-Bore 3-T MR Imaging-guided Prostate Biopsy: A Prospective Clinical Observational Study [J].
Penzkofer, Tobias ;
Tuncali, Kemal ;
Fedorov, Andriy ;
Song, Sang-Eun ;
Tokuda, Junichi ;
Fennessy, Fiona M. ;
Vangel, Mark G. ;
Kibel, Adam S. ;
Mulkern, Robert V. ;
Wells, William M. ;
Hata, Nobuhiko ;
Tempany, Clare M. C. .
RADIOLOGY, 2015, 274 (01) :170-180
[65]   Prostate biopsy: results and advantages of the transperineal approach-twenty-year experience of a single center [J].
Pepe, Pietro ;
Aragona, Francesco .
WORLD JOURNAL OF UROLOGY, 2014, 32 (02) :373-377
[66]   Morbidity After Transperineal Prostate Biopsy in 3000 Patients Undergoing 12 vs 18 vs More Than 24 Needle Cores [J].
Pepe, Pietro ;
Aragona, Francesco .
UROLOGY, 2013, 81 (06) :1142-1146
[67]   Complications following prostate needle biopsy requiring hospital admission or emergency department visits - experience from 1000 consecutive cases [J].
Pinkhasov, G. Igor ;
Lin, Yu-Kuan ;
Palmerola, Ricardo ;
Smith, Paul ;
Mahon, Frank ;
Kaag, Matthew G. ;
Dagen, J. Edward ;
Harpster, Lewis E. ;
Reese, Carl T. ;
Raman, Jay D. .
BJU INTERNATIONAL, 2012, 110 (03) :369-374
[68]   Mortality and complications after prostate biopsy in the Prostate, Lung, Colorectal and Ovarian Cancer Screening (PLCO) trial [J].
Pinsky, Paul F. ;
Parnes, Howard L. ;
Andriole, Gerald .
BJU INTERNATIONAL, 2014, 113 (02) :254-259
[69]   Reducing the risk of infection for transrectal prostate biopsy with povidone-iodine: a systematic review and meta-analysis [J].
Pu, Chunxiao ;
Bai, Yunjin ;
Yuan, Haichao ;
Li, Jinhong ;
Tang, Yin ;
Wang, Jia ;
Wei, Qiang ;
Han, Ping .
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2014, 46 (09) :1691-1698
[70]   Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program [J].
Raaijmakers, R ;
Kirkels, WJ ;
Roobol, MJ ;
Wildhagen, MF ;
Schröder, FH .
UROLOGY, 2002, 60 (05) :826-830